Structure Therapeutics (GPCR) News Today

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

$36.36

+0.18 (+0.50%)

(As of 04:00 PM ET)

Source

Source	Headline
	Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Purchased by Federated Hermes Inc. marketbeat.com - April 19 at 8:27 AM
	Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates. msn.com - April 18 at 1:03 PM
	Structure Therapeutics' (GPCR) "Overweight" Rating Reaffirmed at Cantor Fitzgerald marketbeat.com - April 18 at 10:28 AM
	Analysts Expect This 'Strong Buy' Weight-Loss Stock to Double theglobeandmail.com - April 18 at 8:02 AM
	Structure Therapeutics Inc. (GPCR) finance.yahoo.com - April 16 at 3:32 PM
	Structure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Update marketbeat.com - April 14 at 11:14 PM
	Structure Therapeutics Inc. Expected to Earn FY2024 Earnings of ($1.10) Per Share (NASDAQ:GPCR) americanbankingnews.com - April 13 at 2:20 AM
	Cantor Fitzgerald Comments on Structure Therapeutics Inc.'s FY2024 Earnings (NASDAQ:GPCR) marketbeat.com - April 12 at 6:40 AM
	Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $85.71 Consensus Price Target from Brokerages americanbankingnews.com - April 12 at 1:12 AM
	Buy Rating Affirmed for Structure Therapeutics on Upcoming GSBR-1290 Phase 2a Data Optimism markets.businessinsider.com - April 11 at 9:46 AM
	Buy Rating for Structure Therapeutics on Strong Obesity Drug Prospects and Strategic Partnerships markets.businessinsider.com - April 10 at 2:11 PM
	Structure Therapeutics (NASDAQ:GPCR) Now Covered by Analysts at Cantor Fitzgerald americanbankingnews.com - April 10 at 4:16 AM
	Cantor starts Structure at overweight, sees positive data for GLP-1 drug msn.com - April 9 at 2:56 PM
	Structure Therapeutics (NASDAQ:GPCR) Stock Price Down 5.5% marketbeat.com - April 9 at 2:46 PM
	Cantor Fitzgerald Initiates Coverage on Structure Therapeutics (NASDAQ:GPCR) marketbeat.com - April 9 at 8:24 AM
	Structure Therapeutics Inc. (NASDAQ:GPCR) Receives Consensus Recommendation of "Buy" from Brokerages marketbeat.com - April 9 at 8:12 AM
	Lifesci Capital Weighs in on Structure Therapeutics Inc.'s Q1 2024 Earnings (NASDAQ:GPCR) marketbeat.com - April 3 at 6:00 AM
	7 Small-Cap Stocks that Wall Street Loves for Good Reason investorplace.com - March 30 at 9:37 AM
	Structure Therapeutics (NASDAQ:GPCR) Stock Price Down 3.4% marketbeat.com - March 27 at 1:42 PM
	Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $38.63 marketbeat.com - March 21 at 3:14 PM
	FY2024 EPS Estimates for Structure Therapeutics Inc. Decreased by Leerink Partnrs (NASDAQ:GPCR) marketbeat.com - March 21 at 8:06 AM
	Structure Therapeutics (NASDAQ:GPCR) Trading Up 5% marketbeat.com - March 20 at 3:13 PM
	Q1 2024 Earnings Forecast for Structure Therapeutics Inc. (NASDAQ:GPCR) Issued By Leerink Partnrs marketbeat.com - March 20 at 5:45 AM
	GPCR Dec 2024 50.000 call finance.yahoo.com - March 20 at 5:30 AM
	Wellington Management Group LLP Purchases 657,310 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) marketbeat.com - March 20 at 4:39 AM
	GPCR Sep 2024 30.000 put finance.yahoo.com - March 17 at 5:00 PM
	GPCR May 2024 30.000 put finance.yahoo.com - March 16 at 5:49 PM
	GPCR Apr 2024 30.000 put finance.yahoo.com - March 16 at 5:49 PM
	GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q4 2023 msn.com - March 15 at 11:16 AM
	Structure Therapeutics (NASDAQ:GPCR) Trading Up 2.4% marketbeat.com - March 14 at 1:23 PM
	Former CFO sues Peninsula drug company, alleges domestic violence incident led to her firing bizjournals.com - March 13 at 2:06 PM
	We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth finance.yahoo.com - March 10 at 1:47 PM
	GPCR Mar 2024 40.000 put finance.yahoo.com - March 9 at 7:10 PM
	Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference globenewswire.com - March 8 at 4:05 PM
	Structure Therapeutics (NASDAQ:GPCR) Shares Up 8.3% marketbeat.com - March 8 at 12:43 PM
	Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights globenewswire.com - March 8 at 8:30 AM
	Buy Rating Affirmed for Structure Therapeutics Amidst Competitive Landscape and Promising Drug Prospects markets.businessinsider.com - March 8 at 2:14 AM
	Structure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Up 7.3% in February marketbeat.com - March 5 at 3:17 PM
	Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Purchased by Adage Capital Partners GP L.L.C. marketbeat.com - March 4 at 10:45 AM
	Lifesci Capital Reaffirms "Outperform" Rating for Structure Therapeutics (NASDAQ:GPCR) marketbeat.com - March 2 at 6:17 AM
	230,761 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Purchased by MPM Bioimpact LLC marketbeat.com - March 1 at 10:19 AM
	Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Acquired by Fmr LLC marketbeat.com - February 28 at 5:29 AM
	Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by Monashee Investment Management LLC marketbeat.com - February 25 at 10:46 AM
	Structure Therapeutics Stock (NASDAQ:GPCR), Short Interest Report benzinga.com - February 23 at 8:10 PM
	Structure Therapeutics Stock (NASDAQ:GPCR) Dividends: History, Yield and Dates benzinga.com - February 23 at 10:09 AM
	Federated Hermes Inc. Purchases 95,500 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) marketbeat.com - February 23 at 8:38 AM
	GPCR Mar 2024 60.000 call ca.finance.yahoo.com - February 20 at 12:52 PM
	Baron Opportunity Fund Q4 2023 Shareholder Letter seekingalpha.com - February 18 at 10:54 AM
	Structure Therapeutics Inc. (NASDAQ:GPCR) Given Average Rating of "Buy" by Analysts marketbeat.com - February 12 at 3:24 AM
	150,958 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Victory Capital Management Inc. marketbeat.com - February 7 at 5:02 AM

Get Structure Therapeutics News Delivered to You Automatically

Forget NVIDIA, buy this $2 AI stock now… (Ad)

This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.

Click here to learn more >>>

GPCR Media Mentions By Week

GPCR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GPCR
News Sentiment
▼
0.87

0.52
▲
Average
Medical
News Sentiment

GPCR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GPCR Articles
This Week
▼
10

2
▲
GPCR Articles
Average Week

Get Structure Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:GPCR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Structure Therapeutics (GPCR) News Today

GPCR Media Mentions By Week

GPCR Media Sentiment

GPCR News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info